Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2025 Jul 1;39(8):995-1004.
doi: 10.1097/QAD.0000000000004167. Epub 2025 Mar 18.

Implementing HIV teams sustainably improves HIV indicator condition testing rates in hospitals in the Netherlands: the #aware.hiv clinical trial

Carlijn C E Jordans  1 , Klaske Vliegenthart-Jongbloed  1   2 , Kara K Osbak  1   3 , Jaap L J Hanssen  4 , Jan van Beek  2 , Marion Vriesde  2 , Natasja van Holten  4 , Willemien Dorama  4 , Dorien van der Sluis  4 , Jurriaan de Steenwinkel  2 , Jeroen van Kampen  5 , Annelies Verbon  6 , Anna H E Roukens  4 , Casper Rokx  1   2
Affiliations
Clinical Trial

Implementing HIV teams sustainably improves HIV indicator condition testing rates in hospitals in the Netherlands: the #aware.hiv clinical trial

Carlijn C E Jordans et al. AIDS. .

Abstract

Objective: Develop and validate a strategy to improve HIV testing rates using HIV teams.

Design: A prospective clinical trial was conducted from January 2020 to July 2023 in two Dutch university hospitals.

Methods: The intervention involved implementing HIV teams to provide peer awareness, education, and feedback to physicians treating patients ≥18 years newly diagnosed with HIV indicator conditions. The primary outcome was the HIV testing rate. Secondary outcomes included testing rates by specialty, HIV prevalence, and reasons for withholding testing.

Results: Of the 313 666 newly registered diagnoses, 2395 involved indicator conditions. The overall HIV testing rate of newly diagnosed HIV indicator conditions increased from 50.1% (222/443) preimplementation to 80.7% (1575/1952) postimplementation of HIV teams ( P < 0.001) with sustained improvement during the observation period (range 72.4-90.4%). The intervention was effective across physicians from all medical specialties. HIV prevalence among those tested was 0.6% [95% confidence interval (CI) 0.3-1.1]. Peer feedback for 411 untested indicator conditions, resulted in 69 (16.3%) additional HIV tests. Failure to test frequently remained without reason (50.6%) or due to patient loss of follow-up (18.4%). Multivariate analysis indicated that women with indicator conditions were tested less often [adjusted odds ratio (aOR) 0.59, 95% CI 0.45-0.79, P < 0.01], and indicator conditions without HIV testing recommendations in national guidelines were also less likely to be tested for HIV (aOR 0.36, 95% CI 0.27-0.48, P < 0.01). For external validation, we implemented this intervention in a second hospital, where it also significantly increased the testing rate postimplementation of HIV teams.

Conclusion: Implementing HIV teams in hospitals is feasible, effective and leads to a sustained increase in HIV indicator condition-guided testing, supporting its broader adoption.

Keywords: HIV; HIV indicator condition; HIV positivity rate; HIV testing; healthcare practitioner; hospital; sexually transmitted infections.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Fig. 1
Fig. 1
Flowchart of HIV indicator conditions at EMC postimplementation of HIV teams.
Fig. 2
Fig. 2
Overall HIV testing rate over time, pre and postimplementation of HIV teams.
Fig. 3
Fig. 3
HIV testing rates over time per specialty, pre- and postimplementation of HIV teams.
See this image and copyright information in PMC

References

    1. Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. . Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet 2019; 393:2428–2438. - PMC - PubMed
    1. Tominski D, Katchanov J, Driesch D, Daley MB, Liedtke A, Schneider A, et al. . The late-presenting HIV-infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis. HIV Med 2017; 18:125–132. - PubMed
    1. Guaraldi G, Zona S, Menozzi M, Brothers TD, Carli F, Stentarelli C, et al. . Late presentation increases risk and costs of noninfectious comorbidities in people with HIV: an Italian cost impact study. AIDS Res Ther 2017; 14:8. - PMC - PubMed
    1. Ab E, Bruggeling NM, Donker GA, Posthuma J, Schep A, Stam AJ, et al. NHG-Standaard het soa-consult. 2023.
    1. Europe Hi. HIV indicator conditions: guidance for implementing HIV testing in adults in healthcare settings. 2013.

Publication types